Health
CASI Pharmaceuticals Reports Q3 2024 Financial Results and Clinical Trial Advancements in China
BEIJING, CHINA, November 15, 2024 (Newswire.com) – CASI Pharmaceuticals, Inc. (Nasdaq:CASI) (“CASI” or the “Company”), a biopharmaceutical entity based in the Cayman Islands, actively engaged
November 16, 2024
No Comments